Curium Confirms No Supply Challenges in North America and Europe for Its Eclipse Phase III Clinical Trial

Curium confirmed that the company has no foreseeable supply challenges of 177Lu-PSMA-I&T for the company’s ECLIPSE Phase III clinical trial ongoing in the USA, France, Spain, and Italy.